Difference between revisions of "Rudnicki 2014 United States Patent Application Publication"
From Bioblast
Bader Helga (talk | contribs) |
|||
| Line 14: | Line 14: | ||
|diseases=Obesity | |diseases=Obesity | ||
|couplingstates=LEAK, OXPHOS, ETS | |couplingstates=LEAK, OXPHOS, ETS | ||
|substratestates=CI, CII, | |substratestates=CI, CII, FAO, CI&II, ROX | ||
|instruments=Oxygraph-2k | |instruments=Oxygraph-2k | ||
|additional=Labels | |additional=Labels | ||
}} | }} | ||
Revision as of 17:42, 7 December 2015
| Rudnicki MA, Yin Hang (2014) MICRORNA INHIBITORS. United States Patent Application Publication 1-49. |
Rudnicki MA, Yin Hang (2014) United States Patent Application Publication
Abstract: The present invention relates to microRNAs (miRNAs) that are associated with obesity. The present invention is directed to methods, compounds, and compositions for preventing and treating obesity, as well as related diseases, using a microRNA inhibitor.
Labels: MiParea: Respiration, Patients
Pathology: Obesity
Organism: Human Tissue;cell: Skeletal muscle Preparation: Intact cells, Permeabilized cells
Coupling state: LEAK, OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property.
HRR: Oxygraph-2k
Labels
